About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Clinical Chemistry and Hematology
›
top-articles
Department of Clinical Chemistry and Hematology
165
(top 1%)
papers
8.1K
(top 1%)
citations
41
(top 1%)
h
-index
87
(top 1%)
g
-index
167
all documents
8.6K
doc citations
2.1K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Extracellular vesicles for drug delivery
Advanced Drug Delivery Reviews
2016
866
2
Curcumin nanoformulations: A review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment
Biomaterials
2014
698
3
Cellular stress conditions are reflected in the protein and RNA content of endothelial cell‐derived exosomes
Journal of Extracellular Vesicles
2012
493
4
Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1
Blood
2010
309
5
F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis
Blood
2012
305
6
Extracellular Vesicles: Potential Roles in Regenerative Medicine
Frontiers in Immunology
2014
263
7
3D Bioprinting: from Benches to Translational Applications
Small
2019
235
8
Possibilities and limitations of current technologies for quantification of biological extracellular vesicles and synthetic mimics
Journal of Controlled Release
2015
225
9
The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction
European Heart Journal
2017
222
10
eHealth as the Next-Generation Perinatal Care: An Overview of the Literature
Journal of Medical Internet Research
2018
215
11
Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab
Haematologica
2011
212
12
β2‐Glycoprotein I: evolution, structure and function
Journal of Thrombosis and Haemostasis
2011
180
13
3D‐Bioprinted Mini‐Brain: A Glioblastoma Model to Study Cellular Interactions and Therapeutics
Advanced Materials
2019
168
14
Platelet secretory behaviour: as diverse as the granules … or not?
Journal of Thrombosis and Haemostasis
2015
165
15
The platelet interior revisited: electron tomography reveals tubular α-granule subtypes
Blood
2010
156
16
Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?
Fertility and Sterility
2014
154
17
Novel exon 12 mutations in the HIF2A gene associated with erythrocytosis
Blood
2008
113
18
Extracellular vesicles for nucleic acid delivery: progress and prospects for safe RNA-based gene therapy
Gene Therapy
2017
106
19
Synergistic Effects of Hypofibrinolysis and Genetic and Acquired Risk Factors on the Risk of a First Venous Thrombosis
PLoS Medicine
2008
96
20
Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells
Leukemia
2009
95
21
Immune responses against domain I of β2-glycoprotein I are driven by conformational changes: Domain I of β2-glycoprotein I harbors a cryptic immunogenic epitope
Arthritis and Rheumatism
2011
94
22
The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies
Blood Cancer Journal
2011
92
23
Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4
+
CD25
–
cells
European Journal of Immunology
2008
91
24
Verification and quality control of routine hematology analyzers
International Journal of Laboratory Hematology
2016
88
25
Bioprinting: 3D Bioprinting: from Benches to Translational Applications (Small 23/2019)
Small
2019
84
26
Platelet‐reactivity tests identify patients at risk of secondary cardiovascular events: a systematic review and meta‐analysis
Journal of Thrombosis and Haemostasis
2014
83
27
Plasma levels of fibrinolytic proteins and the risk of myocardial infarction in men
Blood
2010
73
28
Monoclonal antibody-based therapy as a new treatment strategy in multiple myeloma
Leukemia
2012
72
29
Development and evaluation of in vivo tissue engineered blood vessels in a porcine model
Biomaterials
2016
70
30
Autoantibodies Directed Against Domain I of Beta2-Glycoprotein I
Current Rheumatology Reports
2011
69
31
The Impact of the Fibrinolytic System on the Risk of Venous and Arterial Thrombosis
Seminars in Thrombosis and Hemostasis
2009
65
32
A role for activated endothelial cells in red blood cell clearance: implications for vasopathology
Haematologica
2012
64
33
Leukocyte-associated Ig-like receptor-1 is a novel inhibitory receptor for surfactant protein D
Journal of Leukocyte Biology
2014
64
34
Factor XII: form determines function
Journal of Thrombosis and Haemostasis
2016
62
35
Cirrhosis patients have a coagulopathy that is associated with decreased clot formation capacity
Journal of Thrombosis and Haemostasis
2014
60
36
Red Cell Properties after Different Modes of Blood Transportation
Frontiers in Physiology
2016
54
37
Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone
Human Reproduction
2015
52
38
Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid
Molecular Psychiatry
2014
51
39
Functional platelet defects in children with severe chronic ITP as tested with 2 novel assays applicable for low platelet counts
Blood
2014
46
40
Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicity
Blood Advances
2020
45
41
Identification of minor histocompatibility antigens based on the 1000 Genomes Project
Haematologica
2014
43
42
Optimization and validation of moving average quality control procedures using bias detection curves and moving average validation charts
Clinical Chemistry and Laboratory Medicine
2017
40
43
Biofabrication of Cell-Derived Nanovesicles: A Potential Alternative to Extracellular Vesicles for Regenerative Medicine
Cells
2019
39
44
A nanobody-based method for tracking factor XII activation in plasma
Thrombosis and Haemostasis
2013
38
45
Myocardial fibrosis and pro-fibrotic markers in end-stage heart failure patients during continuous-flow left ventricular assist device support
European Journal of Cardio-thoracic Surgery
2015
38
46
Antimüllerian hormone: prediction of cumulative live birth in gonadotropin-releasing hormone antagonist treatment for in vitro fertilization
Fertility and Sterility
2015
37
47
Fibrinolysis and the risk of venous and arterial thrombosis
Current Opinion in Hematology
2007
35
48
Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1
Leukemia
2013
35
49
New Insights into the Role of Erythrocytes in Thrombus Formation
Seminars in Thrombosis and Hemostasis
2014
35
50
Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance
Haematologica
2016
34
site/software ©
exaly
; All materials licenced under
CC by-SA
.